'India priority mkt for growth'

Pfizer India country president and MD says manufacturing, sales, R&D will grow, amid parent's plan to cut costs

- Naman Suri

• 70% of Pfizer's drug sales in India is produced locally

Pfizer India Ltd, a subsidiary of the American pharmaceutical major, is set to expand its operations despite the massive cost-cutting initiative by its parent, Meenakshi Nevatia, country president and managing director of Pfizer India said in an interview.

"India is a priority market. And Pfizer will only expand in India. So, next year continues to be an expansion, despite the global challenge. The intent right now is to look at how we can expand further and grow manufacturing. We are also looking to expand our sales, as we focus on driving this growth next year and making us commercially grow , too," Nevatia added.